Stefano Pessina - Oct 26, 2022 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Signature
Benjamin S.J. Burman, attorney-in-fact
Stock symbol
WBA
Transactions as of
Oct 26, 2022
Transactions value $
-$1,191,254
Form type
4
Date filed
10/28/2022, 06:39 PM
Previous filing
Nov 3, 2021
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WBA Common Stock, par value $0.01 per share Award $0 +204K +41.37% $0.00 699K Oct 26, 2022 Direct F1, F2
transaction WBA Common Stock, par value $0.01 per share Disposed to Issuer -$1.19M -33.5K -4.8% $35.51 665K Oct 26, 2022 Direct F3
transaction WBA Common Stock, par value $0.01 per share Award $0 +167K +25.09% $0.00 832K Oct 26, 2022 Direct F4
holding WBA Common Stock, par value $0.01 per share 145M Oct 26, 2022 By ASP F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding WBA Employee Stock Option (right to buy) 263K Oct 26, 2022 Common Stock 263K $77.08 Direct F6
holding WBA Employee Stock Option (right to buy) 411K Oct 26, 2022 Common Stock 411K $82.46 Direct F7
holding WBA Employee Stock Option (right to buy) 505K Oct 26, 2022 Common Stock 505K $67.01 Direct F8
holding WBA Employee Stock Option (right to buy) 395K Oct 26, 2022 Common Stock 395K $79.90 Direct F9
holding WBA Employee Stock Option (right to buy) 420K Oct 26, 2022 Common Stock 420K $57.38 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued upon settlement of performance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2019 under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan")
F2 Includes shares underlying restricted stock units issued in lieu of dividends (through October 28, 2022) on outstanding restricted stock units, including 7,491 shares with respect to the restricted stock unit award described in Note (4) below.
F3 Disposition relating to the satisfaction of tax withholding obligations upon the vesting of performance share award granted in accordance with Rule 16b-3.
F4 On October 26, 2022, the Compensation and Leadership Performance Committee determined that the performance criteria applicable to this restricted stock award granted on November 1, 2021 (not a derivative security within the meaning of Rule 16a-1(c)) under the Plan had been satisfied. The shares underlying these restricted stock units will vest on November 1, 2024, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
F5 Shares of Common Stock are held of record by a corporation, Alliance Sante Participations S.A. ("ASP") which is 100% owned by another corporation, NewCIP II S.a r.l., which is 100% controlled by the Reporting Person.
F6 The option vested on February 12, 2019, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
F7 The option vested on November 1, 2019, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
F8 The option vested with respect to 168,068 shares on November 1, 2018, with respect to a further 168,068 shares on November 1, 2019, and with respect to 168,574 shares on November 1, 2020, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
F9 The option vested with respect to 131,555 shares on November 1, 2019, with respect to a further 131,555 shares on November 1, 2020, and with respect to 131,951 shares on November 1, 2021, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
F10 The option vested with respect to 139,916 shares on November 1, 2020 and with respect to a further 139,916 shares on November 1, 2021, and vests with respect to 140,336 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.